Influenza A H1N1 Virus 2009 Synthetic Hemagglutinin and Neuraminidase Peptides for Antibody Detection
Autor: | Yesenia Bermúdez-Álvarez, Guillermina Avila, Karla Rojas-Espinosa, Estefania Grostieta, Ana Flisser, Mirza Romero-Valdovinos, Fernando Martinez-Hernandez, Gilberto Vaughan, Verónica Cruz-Licea |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male 0301 basic medicine Antigenicity Saliva Adolescent Neuraminidase Hemagglutinin (influenza) Young Adult 03 medical and health sciences Influenza A Virus H1N1 Subtype 0302 clinical medicine Humans Aged Aged 80 and over Hemagglutination assay biology Outbreak General Medicine Middle Aged Virology Cross-Sectional Studies Hemagglutinins 030104 developmental biology 030220 oncology & carcinogenesis biology.protein Influenza A (H1N1) virus Female Antibody |
Zdroj: | Archives of Medical Research. 51:436-443 |
ISSN: | 0188-4409 |
Popis: | Background Influenza serologic diagnosis is mainly based on hemagglutination inhibition and microneutralization methods, both methods require handling living viruses under an enhanced biosafety level. Aim The current study was performed for developing an ELISA using synthetic peptides to detect influenza A H1N1 virus 2009 specific antibodies in serum and saliva. Methods Alignments were made with H1N1 hemagglutinin and neuraminidase (HA and NA, respectively) sequences; only conserved sites were used for antigenicity prediction. Two synthetic peptides were assayed; one of neuraminidase (NA15) and one of hemagglutinin (HA-15) and used in ELISA for detecting IgG and IgA antibodies. A cross-sectional study was performed in three municipalities of Mexico City, using negative samples collected before the 2009 influenza outbreak, samples of people who became ill during the outbreak, and samples of the participants in the epidemiological study with or without symptoms. Results The determination of serum IgG antibodies with both peptides allowed differentiating between the post outbreak groups with respect to all others. No differences were found in IgA determination in saliva against both peptides. The frequency of positive participants for NA-15 was 9.5 and 8.8% for HA-15 in serum IgG; whereas the frequency of positive participants for NA-15 was 11%, and for HA-15 was 8.6% for saliva IgA. Conclusions Synthetic peptides of the neuraminidase and hemagglutinin proteins can be used in ELISA for the determination of IgG and IgA antibodies against the influenza A H1N1 virus 2009. |
Databáze: | OpenAIRE |
Externí odkaz: |